Meeting
2021 ASCO Annual Meeting
Disease-free survival as a predictor of overall survival in localized renal cell carcinoma (RCC) following first nephrectomy.
Authors
Naomi B. Haas
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Naomi B. Haas , Yan Song , Jaqueline Willemann Rogerio , Su Zhang , Oluwakayode Adejoro , Christopher Carley , Jingjing Zhu , Rituparna Bhattacharya , James Signorovitch , Murali Sundaram
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4581)
DOI
10.1200/JCO.2021.39.15_suppl.4581
Abstract #
4581
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical usefulness of postoperative serum carcinoembryonic antigen in colorectal cancer patients with liver metastases.
First Author: Koichiro Yoshino
Poster
2019 Genitourinary Cancers Symposium
Prognostic value of loss of chromosome 10q in patients with localized renal cell carcinoma.
First Author: Cedric Michel Lebacle
Poster
2016 Gastrointestinal Cancers Symposium
APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC).
First Author: Margaret A. Tempero
Poster
2016 Genitourinary Cancers Symposium
The role of metastasectomy in patients with renal cell carcinoma with sarcomatoid dedifferentiation: A matched controlled analysis.
First Author: Arun Z. Thomas